Improved Survival Outcomes of African America Men with mCRPC Treated with Sipuleucel-T – Kelvin Moses

Kelvin Moses explores the clinical benefit of sipuleucel-T treatment in African American men with advanced prostate cancer in this conversation with Alicia Morgans. A large volume of evidence has demonstrated that African American men have an increased risk of developing mCRPC and have higher mortality as compared with Caucasian men. Sipuleucel-T has demonstrated a survival benefit in men with…

Read the full article here

Related Articles